Cognitive Behavioural Therapy Market By Services (Anxiety Disorders (Generalized Anxiety Disorders, Obsessive Compulsive Disorder, Panic Disorder, PTSD, Social Anxiety Disorder, Specific Phobia), Attention Deficit Hyperactivity Disorder, Eating Disorders (Anorexia Nervosa, Binge Eating Disorder, Bulimia Nervosa), Mood Disorders (Bipolar Disorder, Depression), Psychotic Disorders, Sexual Disorders, Sleep Disorders, Somatoform Disorder (Body Dysmorphic Disorder, Hypochondriasis, Pain Disorder, Somatisation Disorder), Substance Use Disorders); By End Users (B2B, B2C (Individuals (Adults, Children and Adolescents), Couples, Families)); By Offerings (Online, Online); By Region (U.S., Canada, Mexico, Rest of North America, The UK, France, Germany, Italy, Spain, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, the Netherlands, Luxembourg), Rest of Europe, China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa, Brazil, Argentina, Rest of Latin America) – Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2019 - 2027
Industry Trends
Psychological counselling is witnessing high demand from numerous countries to tackle the mental and emotional problems faced by individuals. Cognitive behaviour therapy is one of the most researched and evidence-based form of psychological counselling which is being used over the past few decades since its introduction by Aaron Beck in 1960. It relies on the basics of the connections between a person’s thoughts, emotions and behaviour. Cognitive behaviour therapy helps to identify unhealthy ways of thinking, feeling and behaving and changes them to improve quality of life. It is a combination of two psychotherapies, which is cognitive therapy and behaviour therapy. In cognitive behaviour therapy, the first step is individual assessment in which the medical professional identifies the problem of a patient, followed by personal education wherein the medical professional makes the patient understand the issue. Later, both the therapist and patient collaboratively set up goals and devise strategies to achieve these goals. Cognitive behaviour therapy has proven its mettle against obsessive compulsive disorder (OCD) which is a repeated, persistent and unwanted occurrence of thoughts, fears or obsessions that causes distress or anxiety. These factors are aiding for the growth of cognitive behavioural therapy market. OCD-UK, a national non-profit organisation, states that 12 in every 1,000 people are affected at any given time by obsessive compulsive disorder in the U.K. Also, the World Health Organization states that obsessive compulsive disorder is amongst top 20 causes of illness-related disability across the globe. Common obsessions include fear of germs, symmetry of things, aggressive thoughts toward other people or oneself and unwanted thoughts about forbidden things such as violence, religion or sex. People suffering from obsessive compulsive disorder may turn to alcohol or drug abuse to minimize anxiety which further worsens the situation. National Institute for Health and Clinical Excellence (NICE) and Anixety and Depression Association of America states that cognitive behaviour therapy is best suited for obsessive compulsive disorders as this treatment focuses on the current issues of a patient which makes it a short-term therapy. Furthermore, it has no proven side effects. Major market players such as Think CBT, Mayo Foundation for Medical Education and Research, OCD Center of Los Angeles California, amongst others, provide cognitive behavioural therapy services for patient with obsessive compulsive disorders. Thus, the growing prevalence of obsessive compulsive disorders is fuelling the growth of cognitive behavioural therapy market across the globe.
However, the emotional information collected by the therapists during counselling sessions can be used for unethical practices which is causing concerns among end-users. This can hinder the growth of the global cognitive behavioural therapy market. A therapist collects various types of information such as therapy notes, test results, patient’s personal information, etc., which can be misused. To tackle privacy concerns, various regulations and policies are being adopted by various government bodies. General Data Protection Regulation of European Union, for instance, was adopted in 2018 to safeguard the transfer of personal information. These polices are expected to overcome the concerns amongst the people regarding data privacy, and in turn propel the growth of global cognitive behavioural therapy market in future years.
The recent outbreak of COVID-19 pandemic has affected economies across continents resulting in severe financial crisis, unemployment and salary cuts. United Nation’s International Labour Organization stated in May 2020 that 1.6 billion informal economy workers could suffer massive livelihood damage. Also, there is high uncertainty about how the longevity of this crisis and the aid for unemployed or underemployed workers, which is affecting the psychological well-being of people. Wockhardt Hospitals of India stated in a press release of April 2020 stated that they witnessed a 20 to 25% rise in number of patients suffering since the outbreak of coronavirus. This rise in anxiety and depression, among the people financially affected by COVID-19, is expected to boost the demand for cognitive behavioural therapy market. The Manitoba government of Canada announced an investment of US$ 3.4 million in March 2020 to provide internet based cognitive behavioural therapy to help cope with anxiety caused by the COVID-19 pandemic.
In terms of revenue, global cognitive behavioural therapy market was valued at US$ 2152.47 Mn in 2018 and is anticipated to grow at a CAGR of 5.06% over the forecast period. The study analyses the market in terms of revenue across all the major regions, which have been bifurcated into countries.
Global Cognitive Behavioural Therapy Market Revenue & Forecast, (US$ Million), 2015 – 2027
Services Outlook:
Mood disorder, including bipolar disorder and depression, is the most common type of psychological disorder. The transforming of social and professional ecosystems greatly impact the mental health of people leading to depression which can be characterized by sadness, loss of interest or pleasure, low self-worth, disturbed sleep, loss of appetite, tiredness, feeling of guilt and poor concentration. World Health Organization stated in January 2020 that more than 264 million people suffer from depression globally, which leads to 800,000 suicides per year. Depression can be long-lasting or recurring. This will substantially hamper an individual’s ability to function normally. Cognitive behavioural therapy is a viable treatment for depression as a therapist helps the patient identify negative or false thoughts and replaces those thoughts with healthier images. Thus, the growing prevalence of depression across the globe is driving the share of mood disorders in global cognitive behavioural therapy market as far as services is concerned.
End User Outlook:
B2C end user segment contributes a prominent share in the global cognitive behavioural therapy market. Counsellors, psychologists or therapists can provide cognitive behavioural therapy, either in one-on-one therapy sessions or small groups. Cognitive behavioural therapy for small groups has recently emerged in the market owing to its lower cost compared to individual and family sessions. For instance, the rate for individual or couples therapy at cognitive behavioural therapy Toronto is around US$ 189 per 50 minutes whereas a group therapy costs for US$ 600 for an 8 week session. This immense difference of cost per hour for group therapies is expected to propel its share in the global cognitive behavioural therapy market.
Regional Outlook:
North America region registered the highest share in global cognitive behavioural therapy market in 2018. For instance, Centers for Disease Control and Prevention agency of the U.S states that 18.3% or 44.7 million American people reported mental illness in 2016 and more than 50% will be diagnosed with a mental illness at some point in their lifetime. The rise in number of individuals affected by mental illnesses is driving the share of North America region in the global cognitive behavioural therapy market.
Competitive Landscape:
The report provides both, qualitative and quantitative research of cognitive behavioural therapy market, as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by these major market participants are also recognized and analyzed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.
Some of the players operating in the cognitive behavioural therapy market are Angus Munro Psychology, Anxiety Solutions CBT, Associated Counsellors & Psychologists, CAMH, CBT Australia, Cognitive Behavioural Therapy Center, Cognitive Behavioural Therapy Los Angeles, Cognitive Behavioural Therapy Services, DR ELIZABETH WOODCOCK & ASSOCIATES, First Psychology Borders, Fortis Healthcare, Jewish General Hospital (Integrated Health and Social Services University Network), LifeStance Health Inc., Mayo Foundation for Medical Education and Research, Nuffield Health, Sydney Clinical Psychology, TELL Japan, themindworks Clinics (HelloSelf Limited), Think CBT and Tokyo Mental Health, amongst others.
Global Cognitive Behavioural Therapy Market:
By Services
- Anxiety Disorders
- Generalized Anxiety Disorders
- Obsessive Compulsive Disorder
- Panic Disorder
- PTSD
- Social Anxiety Disorder
- Specific Phobia
- Attention Deficit Hyperactivity Disorder
- Eating Disorders
- Anorexia Nervosa
- Binge Eating Disorder
- Bulimia Nervosa
- Mood Disorders
- Bipolar Disorder
- Depression
- Psychotic Disorders
- Sexual Disorders
- Sleep Disorders
- Somatoform Disorder
- Body Dysmorphic Disorder
- Hypochondriasis
- Pain Disorder
- Somatisation Disorder
- Substance Use Disorders
By End Users
- B2B
- B2C
- Individuals (Adults, Children and Adolescents)
- Couples
- Families
By Offerings
- Online
- Online
By Geography
- North America
- US
- Canada
- Mexico
- Rest of North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
1. Market
Scope
1.1. Market
Segmentation
1.2. Years
Considered
1.2.1. Historic
Years: 2015 - 2017
1.2.2. Base
Year: 2018
1.2.3. Forecast
Years: 2019 – 2027
2. Key Target
Audiences
3. Research
Methodology
3.1. Primary
Research
3.1.1. Research
Questionnaire
3.1.2. Global
Percentage Breakdown
3.1.3. Primary
Interviews: Key Opinion Leaders (KOLs)
3.2. Secondary
Research
3.2.1. Paid
Databases
3.2.2. Secondary
Sources
3.3. Market
Size Estimates
3.3.1. Top-Down
Approach
3.3.2. Bottom-Up
Approach
3.4. Data
Triangulation Methodology
3.5. Research
Assumptions
4. Recommendations
and Insights from AMI’s Perspective**
5. Holistic
Overview of Cognitive Behavioural Therapy Market
6. Market
Synopsis: Cognitive Behavioural Therapy
Market
7. Cognitive
Behavioural Therapy Market Analysis: Qualitative Perspective
7.1. Introduction
7.1.1. Product
Definition
7.1.2. Industry
Development
7.2. Market Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.3. Trends in Cognitive
Behavioural Therapy Market
7.4. Market
Determinants Radar Chart
7.5. Macro-Economic
and Micro-Economic Indicators: Cognitive Behavioural Therapy Market
7.6. Analysis
of COVID-19 Impact on Cognitive Behavioural Therapy Market
8. Global Cognitive
Behavioural Therapy Market Analysis and Forecasts, 2019 – 2027
8.1. Overview
8.1.1. Global Cognitive
Behavioural Therapy Market Revenue (US$ Mn)
8.2. Global Cognitive
Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By Services
8.2.1. Anxiety
Disorders (Definition, Market Estimation and Penetration, 2015 – 2018, Market
Estimation (2015 – 2018), Market Forecast (2019 – 2027), Compound Annual Growth
Rate (CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle
East and Africa, Latin America) and Information on Generalized Anxiety
Disorders, Obsessive Compulsive Disorder, Panic Disorder, PTSD, Social Anxiety
Disorder, Specific Phobia)
8.2.1.1. Generalized
Anxiety Disorders
8.2.1.2. Obsessive
Compulsive Disorder
8.2.1.3. Panic
Disorder
8.2.1.4. PTSD
8.2.1.5. Social
Anxiety Disorder
8.2.1.6. Specific
Phobia
8.2.2. Attention
Deficit Hyperactivity Disorder
8.2.2.1. Definition
8.2.2.2. Market
Estimation and Penetration, 2015 – 2018
8.2.2.3. Market
Forecast, 2019 – 2027
8.2.2.4. Compound
Annual Growth Rate (CAGR)
8.2.2.5. Regional
Bifurcation
8.2.2.5.1. North
America
8.2.2.5.1.1. Market
Estimation, 2015 – 2018
8.2.2.5.1.2. Market
Forecast, 2019 – 2027
8.2.2.5.2. Europe
8.2.2.5.2.1. Market
Estimation, 2015 – 2018
8.2.2.5.2.2. Market
Forecast, 2019 – 2027
8.2.2.5.3. Asia
Pacific
8.2.2.5.3.1. Market
Estimation, 2015 – 2018
8.2.2.5.3.2. Market
Forecast, 2019 – 2027
8.2.2.5.4. Middle
East and Africa
8.2.2.5.4.1. Market
Estimation, 2015 – 2018
8.2.2.5.4.2. Market
Forecast, 2019 – 2027
8.2.2.5.5. Latin
America
8.2.2.5.5.1. Market
Estimation, 2015 – 2018
8.2.2.5.5.2. Market
Forecast, 2019 – 2027
8.2.3. Eating
Disorders (Definition, Market Estimation and Penetration, 2015 – 2018, Market
Estimation (2015 – 2018), Market Forecast (2019 – 2027), Compound Annual Growth
Rate (CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle
East and Africa, Latin America) and Information on Anorexia Nervosa, Binge
Eating Disorder, Bulimia Nervosa)
8.2.3.1. Anorexia
Nervosa
8.2.3.2. Binge
Eating Disorder
8.2.3.3. Bulimia
Nervosa
8.2.4. Mood
Disorders (Definition, Market Estimation and Penetration, 2015 – 2018, Market
Estimation (2015 – 2018), Market Forecast (2019 – 2027), Compound Annual Growth
Rate (CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle
East and Africa, Latin America) and Information on Bipolar Disorder,
Depression)
8.2.4.1. Bipolar
Disorder
8.2.4.2. Depression
8.2.5. Psychotic
Disorders
8.2.5.1. Definition
8.2.5.2. Market
Estimation and Penetration, 2015 – 2018
8.2.5.3. Market
Forecast, 2019 – 2027
8.2.5.4. Compound
Annual Growth Rate (CAGR)
8.2.5.5. Regional
Bifurcation
8.2.5.5.1. North
America
8.2.5.5.1.1. Market
Estimation, 2015 – 2018
8.2.5.5.1.2. Market
Forecast, 2019 – 2027
8.2.5.5.2. Europe
8.2.5.5.2.1. Market
Estimation, 2015 – 2018
8.2.5.5.2.2. Market
Forecast, 2019 – 2027
8.2.5.5.3. Asia
Pacific
8.2.5.5.3.1. Market
Estimation, 2015 – 2018
8.2.5.5.3.2. Market
Forecast, 2019 – 2027
8.2.5.5.4. Middle
East and Africa
8.2.5.5.4.1. Market
Estimation, 2015 – 2018
8.2.5.5.4.2. Market
Forecast, 2019 – 2027
8.2.5.5.5. Latin
America
8.2.5.5.5.1. Market
Estimation, 2015 – 2018
8.2.5.5.5.2. Market
Forecast, 2019 – 2027
8.2.6. Sexual
Disorders
8.2.6.1. Definition
8.2.6.2. Market
Estimation and Penetration, 2015 – 2018
8.2.6.3. Market
Forecast, 2019 – 2027
8.2.6.4. Compound
Annual Growth Rate (CAGR)
8.2.6.5. Regional
Bifurcation
8.2.6.5.1. North
America
8.2.6.5.1.1. Market
Estimation, 2015 – 2018
8.2.6.5.1.2. Market
Forecast, 2019 – 2027
8.2.6.5.2. Europe
8.2.6.5.2.1. Market
Estimation, 2015 – 2018
8.2.6.5.2.2. Market
Forecast, 2019 – 2027
8.2.6.5.3. Asia
Pacific
8.2.6.5.3.1. Market
Estimation, 2015 – 2018
8.2.6.5.3.2. Market
Forecast, 2019 – 2027
8.2.6.5.4. Middle
East and Africa
8.2.6.5.4.1. Market
Estimation, 2015 – 2018
8.2.6.5.4.2. Market
Forecast, 2019 – 2027
8.2.6.5.5. Latin
America
8.2.6.5.5.1. Market
Estimation, 2015 – 2018
8.2.6.5.5.2. Market
Forecast, 2019 – 2027
8.2.7. Sleep
Disorders
8.2.7.1. Definition
8.2.7.2. Market
Estimation and Penetration, 2015 – 2018
8.2.7.3. Market
Forecast, 2019 – 2027
8.2.7.4. Compound
Annual Growth Rate (CAGR)
8.2.7.5. Regional
Bifurcation
8.2.7.5.1. North
America
8.2.7.5.1.1. Market
Estimation, 2015 – 2018
8.2.7.5.1.2. Market
Forecast, 2019 – 2027
8.2.7.5.2. Europe
8.2.7.5.2.1. Market
Estimation, 2015 – 2018
8.2.7.5.2.2. Market
Forecast, 2019 – 2027
8.2.7.5.3. Asia
Pacific
8.2.7.5.3.1. Market
Estimation, 2015 – 2018
8.2.7.5.3.2. Market
Forecast, 2019 – 2027
8.2.7.5.4. Middle
East and Africa
8.2.7.5.4.1. Market
Estimation, 2015 – 2018
8.2.7.5.4.2. Market
Forecast, 2019 – 2027
8.2.7.5.5. Latin
America
8.2.7.5.5.1. Market
Estimation, 2015 – 2018
8.2.7.5.5.2. Market
Forecast, 2019 – 2027
8.2.8. Somatoform
Disorder (Definition, Market Estimation and Penetration, 2015 – 2018, Market
Estimation (2015 – 2018), Market Forecast (2019 – 2027), Compound Annual Growth
Rate (CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle
East and Africa, Latin America) and Information on Body Dysmorphic Disorder,
Hypochondriasis, Pain Disorder, Somatisation Disorder)
8.2.8.1. Body
Dysmorphic Disorder
8.2.8.2. Hypochondriasis
8.2.8.3. Pain
Disorder
8.2.8.4. Somatisation
Disorder
8.2.9. Substance
Use Disorders
8.2.9.1. Definition
8.2.9.2. Market
Estimation and Penetration, 2015 – 2018
8.2.9.3. Market
Forecast, 2019 – 2027
8.2.9.4. Compound
Annual Growth Rate (CAGR)
8.2.9.5. Regional
Bifurcation
8.2.9.5.1. North
America
8.2.9.5.1.1. Market
Estimation, 2015 – 2018
8.2.9.5.1.2. Market
Forecast, 2019 – 2027
8.2.9.5.2. Europe
8.2.9.5.2.1. Market
Estimation, 2015 – 2018
8.2.9.5.2.2. Market
Forecast, 2019 – 2027
8.2.9.5.3. Asia
Pacific
8.2.9.5.3.1. Market
Estimation, 2015 – 2018
8.2.9.5.3.2. Market
Forecast, 2019 – 2027
8.2.9.5.4. Middle
East and Africa
8.2.9.5.4.1. Market
Estimation, 2015 – 2018
8.2.9.5.4.2. Market
Forecast, 2019 – 2027
8.2.9.5.5. Latin
America
8.2.9.5.5.1. Market
Estimation, 2015 – 2018
8.2.9.5.5.2. Market
Forecast, 2019 – 2027
8.3. Key
Segment for Channeling Investments
8.3.1. By
Services
9. Global Cognitive
Behavioural Therapy Market Analysis and Forecasts, 2019 – 2027
9.1. Overview
9.2. Global Cognitive
Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By End Users
9.2.1. B2B
9.2.1.1. Definition
9.2.1.2. Market
Estimation and Penetration, 2015 – 2018
9.2.1.3. Market
Forecast, 2019 – 2027
9.2.1.4. Compound
Annual Growth Rate (CAGR)
9.2.1.5. Regional
Bifurcation
9.2.1.5.1. North
America
9.2.1.5.1.1. Market
Estimation, 2015 – 2018
9.2.1.5.1.2. Market
Forecast, 2019 – 2027
9.2.1.5.2. Europe
9.2.1.5.2.1. Market
Estimation, 2015 – 2018
9.2.1.5.2.2. Market
Forecast, 2019 – 2027
9.2.1.5.3. Asia
Pacific
9.2.1.5.3.1. Market
Estimation, 2015 – 2018
9.2.1.5.3.2. Market
Forecast, 2019 – 2027
9.2.1.5.4. Middle
East and Africa
9.2.1.5.4.1. Market
Estimation, 2015 – 2018
9.2.1.5.4.2. Market
Forecast, 2019 – 2027
9.2.1.5.5. Latin
America
9.2.1.5.5.1. Market
Estimation, 2015 – 2018
9.2.1.5.5.2. Market
Forecast, 2019 – 2027
9.2.2. B2C
(Definition, Market Estimation and Penetration, 2015 – 2018, Market Estimation
(2015 – 2018), Market Forecast (2019 – 2027), Compound Annual Growth Rate
(CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle East
and Africa, Latin America) and Information on
Individuals (Adults, Children and Adolescents), Couples, Families)
9.2.2.1. Individuals (Adults, Children and Adolescents)
9.2.2.2. Couples
9.2.2.3. Families
9.3. Key
Segment for Channeling Investments
9.3.1. By End
Users
10. Global Cognitive
Behavioural Therapy Market Analysis and Forecasts, 2019 – 2027
10.1. Overview
10.2. Global Cognitive
Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By Offerings
10.2.1. Online
10.2.1.1. Definition
10.2.1.2. Market
Estimation and Penetration, 2015 – 2018
10.2.1.3. Market
Forecast, 2019 – 2027
10.2.1.4. Compound
Annual Growth Rate (CAGR)
10.2.1.5. Regional
Bifurcation
10.2.1.5.1. North
America
10.2.1.5.1.1. Market
Estimation, 2015 – 2018
10.2.1.5.1.2. Market
Forecast, 2019 – 2027
10.2.1.5.2. Europe
10.2.1.5.2.1. Market
Estimation, 2015 – 2018
10.2.1.5.2.2. Market
Forecast, 2019 – 2027
10.2.1.5.3. Asia
Pacific
10.2.1.5.3.1. Market
Estimation, 2015 – 2018
10.2.1.5.3.2. Market
Forecast, 2019 – 2027
10.2.1.5.4. Middle
East and Africa
10.2.1.5.4.1. Market
Estimation, 2015 – 2018
10.2.1.5.4.2. Market
Forecast, 2019 – 2027
10.2.1.5.5. Latin
America
10.2.1.5.5.1. Market
Estimation, 2015 – 2018
10.2.1.5.5.2. Market
Forecast, 2019 – 2027
10.2.2. Offline
10.2.2.1. Definition
10.2.2.2. Market
Estimation and Penetration, 2015 – 2018
10.2.2.3. Market
Forecast, 2019 – 2027
10.2.2.4. Compound
Annual Growth Rate (CAGR)
10.2.2.5. Regional
Bifurcation
10.2.2.5.1. North
America
10.2.2.5.1.1. Market
Estimation, 2015 – 2018
10.2.2.5.1.2. Market
Forecast, 2019 – 2027
10.2.2.5.2. Europe
10.2.2.5.2.1. Market
Estimation, 2015 – 2018
10.2.2.5.2.2. Market
Forecast, 2019 – 2027
10.2.2.5.3. Asia
Pacific
10.2.2.5.3.1. Market
Estimation, 2015 – 2018
10.2.2.5.3.2. Market
Forecast, 2019 – 2027
10.2.2.5.4. Middle
East and Africa
10.2.2.5.4.1. Market
Estimation, 2015 – 2018
10.2.2.5.4.2. Market
Forecast, 2019 – 2027
10.2.2.5.5. Latin
America
10.2.2.5.5.1. Market
Estimation, 2015 – 2018
10.2.2.5.5.2. Market
Forecast, 2019 – 2027
10.3. Key
Segment for Channeling Investments
10.3.1. By
Offerings
11. North
America Cognitive Behavioural Therapy Market Analysis and Forecasts, 2019 -
2027
11.1. Overview
11.1.1. North
America Cognitive Behavioural Therapy Market Revenue (US$ Mn)
11.2. North
America Cognitive Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By
Services
11.2.1. Anxiety
Disorders
11.2.1.1. Generalized
Anxiety Disorders
11.2.1.2. Obsessive
Compulsive Disorder
11.2.1.3. Panic
Disorder
11.2.1.4. PTSD
11.2.1.5. Social
Anxiety Disorder
11.2.1.6. Specific
Phobia
11.2.2. Attention
Deficit Hyperactivity Disorder
11.2.3. Eating
Disorders
11.2.3.1. Anorexia
Nervosa
11.2.3.2. Binge
Eating Disorder
11.2.3.3. Bulimia
Nervosa
11.2.4. Mood
Disorders
11.2.4.1. Bipolar
Disorder
11.2.4.2. Depression
11.2.5. Psychotic
Disorders
11.2.6. Sexual
Disorders
11.2.7. Sleep
Disorders
11.2.8. Somatoform
Disorder
11.2.8.1. Body
Dysmorphic Disorder
11.2.8.2. Hypochondriasis
11.2.8.3. Pain
Disorder
11.2.8.4. Somatisation
Disorder
11.2.9. Substance
Use Disorders
11.3. North
America Cognitive Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By
End Users
11.3.1. B2B
11.3.2. B2C
11.3.2.1. Individuals (Adults, Children and Adolescents)
11.3.2.2. Couples
11.3.2.3. Families
11.4. North
America Cognitive Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By
Offerings
11.4.1. Online
11.4.2. Offline
11.5. North
America Cognitive Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By
Country
11.5.1. U.S
11.5.1.1. U.S Cognitive
Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By Services
11.5.1.1.1. Anxiety
Disorders
11.5.1.1.1.1. Generalized
Anxiety Disorders
11.5.1.1.1.2. Obsessive
Compulsive Disorder
11.5.1.1.1.3. Panic
Disorder
11.5.1.1.1.4. PTSD
11.5.1.1.1.5. Social
Anxiety Disorder
11.5.1.1.1.6. Specific
Phobia
11.5.1.1.2. Attention
Deficit Hyperactivity Disorder
11.5.1.1.3. Eating
Disorders
11.5.1.1.3.1. Anorexia
Nervosa
11.5.1.1.3.2. Binge
Eating Disorder
11.5.1.1.3.3. Bulimia
Nervosa
11.5.1.1.4. Mood
Disorders
11.5.1.1.4.1. Bipolar
Disorder
11.5.1.1.4.2. Depression
11.5.1.1.5. Psychotic
Disorders
11.5.1.1.6. Sexual
Disorders
11.5.1.1.7. Sleep
Disorders
11.5.1.1.8. Somatoform
Disorder
11.5.1.1.8.1. Body
Dysmorphic Disorder
11.5.1.1.8.2. Hypochondriasis
11.5.1.1.8.3. Pain
Disorder
11.5.1.1.8.4. Somatisation
Disorder
11.5.1.1.9. Substance
Use Disorders
11.5.1.2. U.S Cognitive
Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By End Users
11.5.1.2.1. B2B
11.5.1.2.2. B2C
11.5.1.2.2.1. Individuals (Adults, Children and Adolescents)
11.5.1.2.2.2. Couples
11.5.1.2.2.3. Families
11.5.1.3. U.S Cognitive
Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By Offerings
11.5.1.3.1. Online
11.5.1.3.2. Offline
11.5.2. Canada
11.5.2.1. Canada
Cognitive Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By
Services
11.5.2.1.1. Anxiety
Disorders
11.5.2.1.1.1. Generalized
Anxiety Disorders
11.5.2.1.1.2. Obsessive
Compulsive Disorder
11.5.2.1.1.3. Panic
Disorder
11.5.2.1.1.4. PTSD
11.5.2.1.1.5. Social
Anxiety Disorder
11.5.2.1.1.6. Specific
Phobia
11.5.2.1.2. Attention
Deficit Hyperactivity Disorder
11.5.2.1.3. Eating
Disorders
11.5.2.1.3.1. Anorexia
Nervosa
11.5.2.1.3.2. Binge
Eating Disorder
11.5.2.1.3.3. Bulimia
Nervosa
11.5.2.1.4. Mood
Disorders
11.5.2.1.4.1. Bipolar
Disorder
11.5.2.1.4.2. Depression
11.5.2.1.5. Psychotic
Disorders
11.5.2.1.6. Sexual
Disorders
11.5.2.1.7. Sleep
Disorders
11.5.2.1.8. Somatoform
Disorder
11.5.2.1.8.1. Body
Dysmorphic Disorder
11.5.2.1.8.2. Hypochondriasis
11.5.2.1.8.3. Pain
Disorder
11.5.2.1.8.4. Somatisation
Disorder
11.5.2.1.9. Substance
Use Disorders
11.5.2.2. Canada
Cognitive Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By End
Users
11.5.2.2.1. B2B
11.5.2.2.2. B2C
11.5.2.2.2.1. Individuals (Adults, Children and Adolescents)
11.5.2.2.2.2. Couples
11.5.2.2.2.3. Families
11.5.2.3. Canada
Cognitive Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By
Offerings
11.5.2.3.1. Online
11.5.2.3.2. Offline
11.5.3. Mexico
11.5.3.1. Mexico
Cognitive Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By Services
11.5.3.1.1. Anxiety
Disorders
11.5.3.1.1.1. Generalized
Anxiety Disorders
11.5.3.1.1.2. Obsessive
Compulsive Disorder
11.5.3.1.1.3. Panic
Disorder
11.5.3.1.1.4. PTSD
11.5.3.1.1.5. Social
Anxiety Disorder
11.5.3.1.1.6. Specific
Phobia
11.5.3.1.2. Attention
Deficit Hyperactivity Disorder
11.5.3.1.3. Eating
Disorders
11.5.3.1.3.1. Anorexia
Nervosa
11.5.3.1.3.2. Binge
Eating Disorder
11.5.3.1.3.3. Bulimia
Nervosa
11.5.3.1.4. Mood
Disorders
11.5.3.1.4.1. Bipolar
Disorder
11.5.3.1.4.2. Depression
11.5.3.1.5. Psychotic
Disorders
11.5.3.1.6. Sexual
Disorders
11.5.3.1.7. Sleep
Disorders
11.5.3.1.8. Somatoform
Disorder
11.5.3.1.8.1. Body
Dysmorphic Disorder
11.5.3.1.8.2. Hypochondriasis
11.5.3.1.8.3. Pain
Disorder
11.5.3.1.8.4. Somatisation
Disorder
11.5.3.1.9. Substance
Use Disorders
11.5.3.2. Mexico
Cognitive Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By End
Users
11.5.3.2.1. B2B
11.5.3.2.2. B2C
11.5.3.2.2.1. Individuals (Adults, Children and Adolescents)
11.5.3.2.2.2. Couples
11.5.3.2.2.3. Families
11.5.3.3. Mexico
Cognitive Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By
Offerings
11.5.3.3.1. Online
11.5.3.3.2. Offline
11.5.4. Rest of
North America
11.5.4.1. Rest
of North America Cognitive Behavioural Therapy Market Revenue (US$ Mn) and
Forecasts, By Services
11.5.4.1.1. Anxiety
Disorders
11.5.4.1.1.1. Generalized
Anxiety Disorders
11.5.4.1.1.2. Obsessive
Compulsive Disorder
11.5.4.1.1.3. Panic
Disorder
11.5.4.1.1.4. PTSD
11.5.4.1.1.5. Social
Anxiety Disorder
11.5.4.1.1.6. Specific
Phobia
11.5.4.1.2. Attention
Deficit Hyperactivity Disorder
11.5.4.1.3. Eating
Disorders
11.5.4.1.3.1. Anorexia
Nervosa
11.5.4.1.3.2. Binge
Eating Disorder
11.5.4.1.3.3. Bulimia
Nervosa
11.5.4.1.4. Mood
Disorders
11.5.4.1.4.1. Bipolar
Disorder
11.5.4.1.4.2. Depression
11.5.4.1.5. Psychotic
Disorders
11.5.4.1.6. Sexual
Disorders
11.5.4.1.7. Sleep
Disorders
11.5.4.1.8. Somatoform
Disorder
11.5.4.1.8.1. Body
Dysmorphic Disorder
11.5.4.1.8.2. Hypochondriasis
11.5.4.1.8.3. Pain
Disorder
11.5.4.1.8.4. Somatisation
Disorder
11.5.4.1.9. Substance
Use Disorders
11.5.4.2. Rest
of North America Cognitive Behavioural Therapy Market Revenue (US$ Mn) and
Forecasts, By End Users
11.5.4.2.1. B2B
11.5.4.2.2. B2C
11.5.4.2.2.1. Individuals (Adults, Children and Adolescents)
11.5.4.2.2.2. Couples
11.5.4.2.2.3. Families
11.5.4.3. Rest
of North America Cognitive Behavioural Therapy Market Revenue (US$ Mn) and
Forecasts, By Offerings
11.5.4.3.1. Online
11.5.4.3.2. Offline
11.6. Key
Segment for Channeling Investments
11.6.1. By
Country
11.6.2. By
Services
11.6.3. By End
Users
11.6.4. By
Offerings
12. Europe Cognitive
Behavioural Therapy Market Analysis and Forecasts, 2019 - 2027
12.1. Overview
12.1.1. Europe Cognitive
Behavioural Therapy Market Revenue (US$ Mn)
12.2. Europe Cognitive
Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By Services
12.2.1. Anxiety
Disorders
12.2.1.1. Generalized
Anxiety Disorders
12.2.1.2. Obsessive
Compulsive Disorder
12.2.1.3. Panic
Disorder
12.2.1.4. PTSD
12.2.1.5. Social
Anxiety Disorder
12.2.1.6. Specific
Phobia
12.2.2. Attention
Deficit Hyperactivity Disorder
12.2.3. Eating
Disorders
12.2.3.1. Anorexia
Nervosa
12.2.3.2. Binge
Eating Disorder
12.2.3.3. Bulimia
Nervosa
12.2.4. Mood
Disorders
12.2.4.1. Bipolar
Disorder
12.2.4.2. Depression
12.2.5. Psychotic
Disorders
12.2.6. Sexual
Disorders
12.2.7. Sleep
Disorders
12.2.8. Somatoform
Disorder
12.2.8.1. Body
Dysmorphic Disorder
12.2.8.2. Hypochondriasis
12.2.8.3. Pain
Disorder
12.2.8.4. Somatisation
Disorder
12.2.9. Substance
Use Disorders
12.3. Europe Cognitive
Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By End Users
12.3.1. B2B
12.3.2. B2C
12.3.2.1. Individuals (Adults, Children and Adolescents)
12.3.2.2. Couples
12.3.2.3. Families
12.4. Europe Cognitive
Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By Offerings
12.4.1. Online
12.4.2. Offline
12.5. Europe Cognitive
Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By Country
12.5.1. France
12.5.1.1. France
Cognitive Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By
Services
12.5.1.1.1. Anxiety
Disorders
12.5.1.1.1.1. Generalized
Anxiety Disorders
12.5.1.1.1.2. Obsessive
Compulsive Disorder
12.5.1.1.1.3. Panic
Disorder
12.5.1.1.1.4. PTSD
12.5.1.1.1.5. Social
Anxiety Disorder
12.5.1.1.1.6. Specific
Phobia
12.5.1.1.2. Attention
Deficit Hyperactivity Disorder
12.5.1.1.3. Eating
Disorders
12.5.1.1.3.1. Anorexia
Nervosa
12.5.1.1.3.2. Binge
Eating Disorder
12.5.1.1.3.3. Bulimia
Nervosa
12.5.1.1.4. Mood
Disorders
12.5.1.1.4.1. Bipolar
Disorder
12.5.1.1.4.2. Depression
12.5.1.1.5. Psychotic
Disorders
12.5.1.1.6. Sexual
Disorders
12.5.1.1.7. Sleep
Disorders
12.5.1.1.8. Somatoform
Disorder
12.5.1.1.8.1. Body
Dysmorphic Disorder
12.5.1.1.8.2. Hypochondriasis
12.5.1.1.8.3. Pain
Disorder
12.5.1.1.8.4. Somatisation
Disorder
12.5.1.1.9. Substance
Use Disorders
12.5.1.2. France
Cognitive Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By End
Users
12.5.1.2.1. B2B
12.5.1.2.2. B2C
12.5.1.2.2.1. Individuals (Adults, Children and Adolescents)
12.5.1.2.2.2. Couples
12.5.1.2.2.3. Families
12.5.1.3. France
Cognitive Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By
Offerings
12.5.1.3.1. Online
12.5.1.3.2. Offline
12.5.2. The UK
12.5.2.1. The
UK Cognitive Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By
Services
12.5.2.1.1. Anxiety
Disorders
12.5.2.1.1.1. Generalized
Anxiety Disorders
12.5.2.1.1.2. Obsessive
Compulsive Disorder
12.5.2.1.1.3. Panic
Disorder
12.5.2.1.1.4. PTSD
12.5.2.1.1.5. Social
Anxiety Disorder
12.5.2.1.1.6. Specific
Phobia
12.5.2.1.2. Attention
Deficit Hyperactivity Disorder
12.5.2.1.3. Eating
Disorders
12.5.2.1.3.1. Anorexia
Nervosa
12.5.2.1.3.2. Binge
Eating Disorder
12.5.2.1.3.3. Bulimia
Nervosa
12.5.2.1.4. Mood
Disorders
12.5.2.1.4.1. Bipolar
Disorder
12.5.2.1.4.2. Depression
12.5.2.1.5. Psychotic
Disorders
12.5.2.1.6. Sexual
Disorders
12.5.2.1.7. Sleep
Disorders
12.5.2.1.8. Somatoform
Disorder
12.5.2.1.8.1. Body
Dysmorphic Disorder
12.5.2.1.8.2. Hypochondriasis
12.5.2.1.8.3. Pain
Disorder
12.5.2.1.8.4. Somatisation
Disorder
12.5.2.1.9. Substance
Use Disorders
12.5.2.2. The
UK Cognitive Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By End
Users
12.5.2.2.1. B2B
12.5.2.2.2. B2C
12.5.2.2.2.1. Individuals (Adults, Children and Adolescents)
12.5.2.2.2.2. Couples
12.5.2.2.2.3. Families
12.5.2.3. The
UK Cognitive Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By
Offerings
12.5.2.3.1. Online
12.5.2.3.2. Offline
12.5.3. Spain
12.5.3.1. Spain
Cognitive Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By
Services
12.5.3.1.1. Anxiety
Disorders
12.5.3.1.1.1. Generalized
Anxiety Disorders
12.5.3.1.1.2. Obsessive
Compulsive Disorder
12.5.3.1.1.3. Panic
Disorder
12.5.3.1.1.4. PTSD
12.5.3.1.1.5. Social
Anxiety Disorder
12.5.3.1.1.6. Specific
Phobia
12.5.3.1.2. Attention
Deficit Hyperactivity Disorder
12.5.3.1.3. Eating
Disorders
12.5.3.1.3.1. Anorexia
Nervosa
12.5.3.1.3.2. Binge
Eating Disorder
12.5.3.1.3.3. Bulimia
Nervosa
12.5.3.1.4. Mood
Disorders
12.5.3.1.4.1. Bipolar
Disorder
12.5.3.1.4.2. Depression
12.5.3.1.5. Psychotic
Disorders
12.5.3.1.6. Sexual
Disorders
12.5.3.1.7. Sleep
Disorders
12.5.3.1.8. Somatoform
Disorder
12.5.3.1.8.1. Body
Dysmorphic Disorder
12.5.3.1.8.2. Hypochondriasis
12.5.3.1.8.3. Pain
Disorder
12.5.3.1.8.4. Somatisation
Disorder
12.5.3.1.9. Substance
Use Disorders
12.5.3.2. Spain
Cognitive Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By End
Users
12.5.3.2.1. B2B
12.5.3.2.2. B2C
12.5.3.2.2.1. Individuals (Adults, Children and Adolescents)
12.5.3.2.2.2. Couples
12.5.3.2.2.3. Families
12.5.3.3. Spain
Cognitive Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By
Offerings
12.5.3.3.1. Online
12.5.3.3.2. Offline
12.5.4. Germany
12.5.4.1. Germany
Cognitive Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By
Services
12.5.4.1.1. Anxiety
Disorders
12.5.4.1.1.1. Generalized
Anxiety Disorders
12.5.4.1.1.2. Obsessive
Compulsive Disorder
12.5.4.1.1.3. Panic
Disorder
12.5.4.1.1.4. PTSD
12.5.4.1.1.5. Social
Anxiety Disorder
12.5.4.1.1.6. Specific
Phobia
12.5.4.1.2. Attention
Deficit Hyperactivity Disorder
12.5.4.1.3. Eating
Disorders
12.5.4.1.3.1. Anorexia
Nervosa
12.5.4.1.3.2. Binge
Eating Disorder
12.5.4.1.3.3. Bulimia
Nervosa
12.5.4.1.4. Mood
Disorders
12.5.4.1.4.1. Bipolar
Disorder
12.5.4.1.4.2. Depression
12.5.4.1.5. Psychotic
Disorders
12.5.4.1.6. Sexual
Disorders
12.5.4.1.7. Sleep
Disorders
12.5.4.1.8. Somatoform
Disorder
12.5.4.1.8.1. Body
Dysmorphic Disorder
12.5.4.1.8.2. Hypochondriasis
12.5.4.1.8.3. Pain
Disorder
12.5.4.1.8.4. Somatisation
Disorder
12.5.4.1.9. Substance
Use Disorders
12.5.4.2. Germany
Cognitive Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By End
Users
12.5.4.2.1. B2B
12.5.4.2.2. B2C
12.5.4.2.2.1. Individuals (Adults, Children and Adolescents)
12.5.4.2.2.2. Couples
12.5.4.2.2.3. Families
12.5.4.3. Germany
Cognitive Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By
Offerings
12.5.4.3.1. Online
12.5.4.3.2. Offline
12.5.5. Italy
12.5.5.1. Italy
Cognitive Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By
Services
12.5.5.1.1. Anxiety
Disorders
12.5.5.1.1.1. Generalized
Anxiety Disorders
12.5.5.1.1.2. Obsessive
Compulsive Disorder
12.5.5.1.1.3. Panic
Disorder
12.5.5.1.1.4. PTSD
12.5.5.1.1.5. Social
Anxiety Disorder
12.5.5.1.1.6. Specific
Phobia
12.5.5.1.2. Attention
Deficit Hyperactivity Disorder
12.5.5.1.3. Eating
Disorders
12.5.5.1.3.1. Anorexia
Nervosa
12.5.5.1.3.2. Binge
Eating Disorder
12.5.5.1.3.3. Bulimia
Nervosa
12.5.5.1.4. Mood
Disorders
12.5.5.1.4.1. Bipolar
Disorder
12.5.5.1.4.2. Depression
12.5.5.1.5. Psychotic
Disorders
12.5.5.1.6. Sexual
Disorders
12.5.5.1.7. Sleep
Disorders
12.5.5.1.8. Somatoform
Disorder
12.5.5.1.8.1. Body
Dysmorphic Disorder
12.5.5.1.8.2. Hypochondriasis
12.5.5.1.8.3. Pain
Disorder
12.5.5.1.8.4. Somatisation
Disorder
12.5.5.1.9. Substance
Use Disorders
12.5.5.2. Italy
Cognitive Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By End
Users
12.5.5.2.1. B2B
12.5.5.2.2. B2C
12.5.5.2.2.1. Individuals (Adults, Children and Adolescents)
12.5.5.2.2.2. Couples
12.5.5.2.2.3. Families
12.5.5.3. Italy
Cognitive Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By
Offerings
12.5.5.3.1. Online
12.5.5.3.2. Offline
12.5.6. Nordic
Countries
12.5.6.1. Nordic
Countries Cognitive Behavioural Therapy Market Revenue (US$ Mn) and Forecasts,
By Services
12.5.6.1.1. Anxiety
Disorders
12.5.6.1.1.1. Generalized
Anxiety Disorders
12.5.6.1.1.2. Obsessive
Compulsive Disorder
12.5.6.1.1.3. Panic
Disorder
12.5.6.1.1.4. PTSD
12.5.6.1.1.5. Social
Anxiety Disorder
12.5.6.1.1.6. Specific
Phobia
12.5.6.1.2. Attention
Deficit Hyperactivity Disorder
12.5.6.1.3. Eating
Disorders
12.5.6.1.3.1. Anorexia
Nervosa
12.5.6.1.3.2. Binge
Eating Disorder
12.5.6.1.3.3. Bulimia
Nervosa
12.5.6.1.4. Mood
Disorders
12.5.6.1.4.1. Bipolar
Disorder
12.5.6.1.4.2. Depression
12.5.6.1.5. Psychotic
Disorders
12.5.6.1.6. Sexual
Disorders
12.5.6.1.7. Sleep
Disorders
12.5.6.1.8. Somatoform
Disorder
12.5.6.1.8.1. Body
Dysmorphic Disorder
12.5.6.1.8.2. Hypochondriasis
12.5.6.1.8.3. Pain
Disorder
12.5.6.1.8.4. Somatisation
Disorder
12.5.6.1.9. Substance
Use Disorders
12.5.6.2. Nordic
Countries Cognitive Behavioural Therapy Market Revenue (US$ Mn) and Forecasts,
By End Users
12.5.6.2.1. B2B
12.5.6.2.2. B2C
12.5.6.2.2.1. Individuals (Adults, Children and Adolescents)
12.5.6.2.2.2. Couples
12.5.6.2.2.3. Families
12.5.6.3. Nordic
Countries Cognitive Behavioural Therapy Market Revenue (US$ Mn) and Forecasts,
By Offerings
12.5.6.3.1. Online
12.5.6.3.2. Offline
12.5.6.4. Nordic
Countries Cognitive Behavioural Therapy Market Revenue (US$ Mn) and Forecasts,
By Country
12.5.6.4.1. Denmark
12.5.6.4.2. Finland
12.5.6.4.3. Iceland
12.5.6.4.4. Sweden
12.5.6.4.5. Norway
12.5.7. Benelux
Union
12.5.7.1. Benelux
Union Cognitive Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By
Services
12.5.7.1.1. Anxiety
Disorders
12.5.7.1.1.1. Generalized
Anxiety Disorders
12.5.7.1.1.2. Obsessive
Compulsive Disorder
12.5.7.1.1.3. Panic
Disorder
12.5.7.1.1.4. PTSD
12.5.7.1.1.5. Social
Anxiety Disorder
12.5.7.1.1.6. Specific
Phobia
12.5.7.1.2. Attention
Deficit Hyperactivity Disorder
12.5.7.1.3. Eating
Disorders
12.5.7.1.3.1. Anorexia
Nervosa
12.5.7.1.3.2. Binge
Eating Disorder
12.5.7.1.3.3. Bulimia
Nervosa
12.5.7.1.4. Mood
Disorders
12.5.7.1.4.1. Bipolar
Disorder
12.5.7.1.4.2. Depression
12.5.7.1.5. Psychotic
Disorders
12.5.7.1.6. Sexual
Disorders
12.5.7.1.7. Sleep
Disorders
12.5.7.1.8. Somatoform
Disorder
12.5.7.1.8.1. Body
Dysmorphic Disorder
12.5.7.1.8.2. Hypochondriasis
12.5.7.1.8.3. Pain
Disorder
12.5.7.1.8.4. Somatisation
Disorder
12.5.7.1.9. Substance
Use Disorders
12.5.7.2. Benelux
Union Cognitive Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By
End Users
12.5.7.2.1. B2B
12.5.7.2.2. B2C
12.5.7.2.2.1. Individuals (Adults, Children and Adolescents)
12.5.7.2.2.2. Couples
12.5.7.2.2.3. Families
12.5.7.3. Benelux
Union Cognitive Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By
Offerings
12.5.7.3.1. Online
12.5.7.3.2. Offline
12.5.7.4. Benelux
Union Cognitive Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By
Country
12.5.7.4.1. Belgium
12.5.7.4.2. The
Netherlands
12.5.7.4.3. Luxembourg
12.5.8. Rest of
Europe
12.5.8.1. Rest
of Europe Cognitive Behavioural Therapy Market Revenue (US$ Mn) and Forecasts,
By Services
12.5.8.1.1. Anxiety
Disorders
12.5.8.1.1.1. Generalized
Anxiety Disorders
12.5.8.1.1.2. Obsessive
Compulsive Disorder
12.5.8.1.1.3. Panic
Disorder
12.5.8.1.1.4. PTSD
12.5.8.1.1.5. Social
Anxiety Disorder
12.5.8.1.1.6. Specific
Phobia
12.5.8.1.2. Attention
Deficit Hyperactivity Disorder
12.5.8.1.3. Eating
Disorders
12.5.8.1.3.1. Anorexia
Nervosa
12.5.8.1.3.2. Binge
Eating Disorder
12.5.8.1.3.3. Bulimia
Nervosa
12.5.8.1.4. Mood
Disorders
12.5.8.1.4.1. Bipolar
Disorder
12.5.8.1.4.2. Depression
12.5.8.1.5. Psychotic
Disorders
12.5.8.1.6. Sexual
Disorders
12.5.8.1.7. Sleep
Disorders
12.5.8.1.8. Somatoform
Disorder
12.5.8.1.8.1. Body
Dysmorphic Disorder
12.5.8.1.8.2. Hypochondriasis
12.5.8.1.8.3. Pain
Disorder
12.5.8.1.8.4. Somatisation
Disorder
12.5.8.1.9. Substance
Use Disorders
12.5.8.2. Rest
of Europe Cognitive Behavioural Therapy Market Revenue (US$ Mn) and Forecasts,
By End Users
12.5.8.2.1. B2B
12.5.8.2.2. B2C
12.5.8.2.2.1. Individuals (Adults, Children and Adolescents)
12.5.8.2.2.2. Couples
12.5.8.2.2.3. Families
12.5.8.3. Rest
of Europe Cognitive Behavioural Therapy Market Revenue (US$ Mn) and Forecasts,
By Offerings
12.5.8.3.1. Online
12.5.8.3.2. Offline
12.6. Key
Segment for Channeling Investments
12.6.1. By
Country
12.6.2. By
Services
12.6.3. By End
Users
12.6.4. By
Offerings
13. Asia
Pacific Cognitive Behavioural Therapy Market Analysis and Forecasts, 2019 -
2027
13.1. Overview
13.1.1. Asia
Pacific Cognitive Behavioural Therapy Market Revenue (US$ Mn)
13.2. Asia
Pacific Cognitive Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By
Services
13.2.1. Anxiety
Disorders
13.2.1.1. Generalized
Anxiety Disorders
13.2.1.2. Obsessive
Compulsive Disorder
13.2.1.3. Panic
Disorder
13.2.1.4. PTSD
13.2.1.5. Social
Anxiety Disorder
13.2.1.6. Specific
Phobia
13.2.2. Attention
Deficit Hyperactivity Disorder
13.2.3. Eating
Disorders
13.2.3.1. Anorexia
Nervosa
13.2.3.2. Binge
Eating Disorder
13.2.3.3. Bulimia
Nervosa
13.2.4. Mood
Disorders
13.2.4.1. Bipolar
Disorder
13.2.4.2. Depression
13.2.5. Psychotic
Disorders
13.2.6. Sexual
Disorders
13.2.7. Sleep
Disorders
13.2.8. Somatoform
Disorder
13.2.8.1. Body
Dysmorphic Disorder
13.2.8.2. Hypochondriasis
13.2.8.3. Pain
Disorder
13.2.8.4. Somatisation
Disorder
13.2.9. Substance
Use Disorders
13.3. Asia
Pacific Cognitive Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By
End Users
13.3.1. B2B
13.3.2. B2C
13.3.2.1. Individuals (Adults, Children and Adolescents)
13.3.2.2. Couples
13.3.2.3. Families
13.4. Asia
Pacific Cognitive Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By
Offerings
13.4.1. Online
13.4.2. Offline
13.5. Asia
Pacific Cognitive Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By
Country
13.5.1. China
13.5.1.1. China
Cognitive Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By
Services
13.5.1.1.1. Anxiety
Disorders
13.5.1.1.1.1. Generalized
Anxiety Disorders
13.5.1.1.1.2. Obsessive
Compulsive Disorder
13.5.1.1.1.3. Panic
Disorder
13.5.1.1.1.4. PTSD
13.5.1.1.1.5. Social
Anxiety Disorder
13.5.1.1.1.6. Specific
Phobia
13.5.1.1.2. Attention
Deficit Hyperactivity Disorder
13.5.1.1.3. Eating
Disorders
13.5.1.1.3.1. Anorexia
Nervosa
13.5.1.1.3.2. Binge
Eating Disorder
13.5.1.1.3.3. Bulimia
Nervosa
13.5.1.1.4. Mood
Disorders
13.5.1.1.4.1. Bipolar
Disorder
13.5.1.1.4.2. Depression
13.5.1.1.5. Psychotic
Disorders
13.5.1.1.6. Sexual
Disorders
13.5.1.1.7. Sleep
Disorders
13.5.1.1.8. Somatoform
Disorder
13.5.1.1.8.1. Body
Dysmorphic Disorder
13.5.1.1.8.2. Hypochondriasis
13.5.1.1.8.3. Pain
Disorder
13.5.1.1.8.4. Somatisation
Disorder
13.5.1.1.9. Substance
Use Disorders
13.5.1.2. China
Cognitive Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By End
Users
13.5.1.2.1. B2B
13.5.1.2.2. B2C
13.5.1.2.2.1. Individuals (Adults, Children and Adolescents)
13.5.1.2.2.2. Couples
13.5.1.2.2.3. Families
13.5.1.3. China
Cognitive Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By
Offerings
13.5.1.3.1. Online
13.5.1.3.2. Offline
13.5.2. Japan
13.5.2.1. Japan
Cognitive Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By Services
13.5.2.1.1. Anxiety
Disorders
13.5.2.1.1.1. Generalized
Anxiety Disorders
13.5.2.1.1.2. Obsessive
Compulsive Disorder
13.5.2.1.1.3. Panic
Disorder
13.5.2.1.1.4. PTSD
13.5.2.1.1.5. Social
Anxiety Disorder
13.5.2.1.1.6. Specific
Phobia
13.5.2.1.2. Attention
Deficit Hyperactivity Disorder
13.5.2.1.3. Eating
Disorders
13.5.2.1.3.1. Anorexia
Nervosa
13.5.2.1.3.2. Binge
Eating Disorder
13.5.2.1.3.3. Bulimia
Nervosa
13.5.2.1.4. Mood
Disorders
13.5.2.1.4.1. Bipolar
Disorder
13.5.2.1.4.2. Depression
13.5.2.1.5. Psychotic
Disorders
13.5.2.1.6. Sexual
Disorders
13.5.2.1.7. Sleep
Disorders
13.5.2.1.8. Somatoform
Disorder
13.5.2.1.8.1. Body
Dysmorphic Disorder
13.5.2.1.8.2. Hypochondriasis
13.5.2.1.8.3. Pain
Disorder
13.5.2.1.8.4. Somatisation
Disorder
13.5.2.1.9. Substance
Use Disorders
13.5.2.2. Japan
Cognitive Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By End
Users
13.5.2.2.1. B2B
13.5.2.2.2. B2C
13.5.2.2.2.1. Individuals (Adults, Children and Adolescents)
13.5.2.2.2.2. Couples
13.5.2.2.2.3. Families
13.5.2.3. Japan
Cognitive Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By
Offerings
13.5.2.3.1. Online
13.5.2.3.2. Offline
13.5.3. India
13.5.3.1. India
Cognitive Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By
Services
13.5.3.1.1. Anxiety
Disorders
13.5.3.1.1.1. Generalized
Anxiety Disorders
13.5.3.1.1.2. Obsessive
Compulsive Disorder
13.5.3.1.1.3. Panic
Disorder
13.5.3.1.1.4. PTSD
13.5.3.1.1.5. Social
Anxiety Disorder
13.5.3.1.1.6. Specific
Phobia
13.5.3.1.2. Attention
Deficit Hyperactivity Disorder
13.5.3.1.3. Eating
Disorders
13.5.3.1.3.1. Anorexia
Nervosa
13.5.3.1.3.2. Binge
Eating Disorder
13.5.3.1.3.3. Bulimia
Nervosa
13.5.3.1.4. Mood
Disorders
13.5.3.1.4.1. Bipolar
Disorder
13.5.3.1.4.2. Depression
13.5.3.1.5. Psychotic
Disorders
13.5.3.1.6. Sexual
Disorders
13.5.3.1.7. Sleep
Disorders
13.5.3.1.8. Somatoform
Disorder
13.5.3.1.8.1. Body
Dysmorphic Disorder
13.5.3.1.8.2. Hypochondriasis
13.5.3.1.8.3. Pain
Disorder
13.5.3.1.8.4. Somatisation
Disorder
13.5.3.1.9. Substance
Use Disorders
13.5.3.2. India
Cognitive Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By End
Users
13.5.3.2.1. B2B
13.5.3.2.2. B2C
13.5.3.2.2.1. Individuals (Adults, Children and Adolescents)
13.5.3.2.2.2. Couples
13.5.3.2.2.3. Families
13.5.3.3. India
Cognitive Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By
Offerings
13.5.3.3.1. Online
13.5.3.3.2. Offline
13.5.4. New
Zealand
13.5.4.1. New
Zealand Cognitive Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By
Services
13.5.4.1.1. Anxiety
Disorders
13.5.4.1.1.1. Generalized
Anxiety Disorders
13.5.4.1.1.2. Obsessive
Compulsive Disorder
13.5.4.1.1.3. Panic
Disorder
13.5.4.1.1.4. PTSD
13.5.4.1.1.5. Social
Anxiety Disorder
13.5.4.1.1.6. Specific
Phobia
13.5.4.1.2. Attention
Deficit Hyperactivity Disorder
13.5.4.1.3. Eating
Disorders
13.5.4.1.3.1. Anorexia
Nervosa
13.5.4.1.3.2. Binge
Eating Disorder
13.5.4.1.3.3. Bulimia
Nervosa
13.5.4.1.4. Mood
Disorders
13.5.4.1.4.1. Bipolar
Disorder
13.5.4.1.4.2. Depression
13.5.4.1.5. Psychotic
Disorders
13.5.4.1.6. Sexual
Disorders
13.5.4.1.7. Sleep
Disorders
13.5.4.1.8. Somatoform
Disorder
13.5.4.1.8.1. Body
Dysmorphic Disorder
13.5.4.1.8.2. Hypochondriasis
13.5.4.1.8.3. Pain
Disorder
13.5.4.1.8.4. Somatisation
Disorder
13.5.4.1.9. Substance
Use Disorders
13.5.4.2. New
Zealand Cognitive Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By
End Users
13.5.4.2.1. B2B
13.5.4.2.2. B2C
13.5.4.2.2.1. Individuals (Adults, Children and Adolescents)
13.5.4.2.2.2. Couples
13.5.4.2.2.3. Families
13.5.4.3. New
Zealand Cognitive Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By
Offerings
13.5.4.3.1. Online
13.5.4.3.2. Offline
13.5.5. Australia
13.5.5.1. Australia
Cognitive Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By
Services
13.5.5.1.1. Anxiety
Disorders
13.5.5.1.1.1. Generalized
Anxiety Disorders
13.5.5.1.1.2. Obsessive
Compulsive Disorder
13.5.5.1.1.3. Panic
Disorder
13.5.5.1.1.4. PTSD
13.5.5.1.1.5. Social
Anxiety Disorder
13.5.5.1.1.6. Specific
Phobia
13.5.5.1.2. Attention
Deficit Hyperactivity Disorder
13.5.5.1.3. Eating
Disorders
13.5.5.1.3.1. Anorexia
Nervosa
13.5.5.1.3.2. Binge
Eating Disorder
13.5.5.1.3.3. Bulimia
Nervosa
13.5.5.1.4. Mood
Disorders
13.5.5.1.4.1. Bipolar
Disorder
13.5.5.1.4.2. Depression
13.5.5.1.5. Psychotic
Disorders
13.5.5.1.6. Sexual
Disorders
13.5.5.1.7. Sleep
Disorders
13.5.5.1.8. Somatoform
Disorder
13.5.5.1.8.1. Body
Dysmorphic Disorder
13.5.5.1.8.2. Hypochondriasis
13.5.5.1.8.3. Pain
Disorder
13.5.5.1.8.4. Somatisation
Disorder
13.5.5.1.9. Substance
Use Disorders
13.5.5.2. Australia
Cognitive Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By End
Users
13.5.5.2.1. B2B
13.5.5.2.2. B2C
13.5.5.2.2.1. Individuals (Adults, Children and Adolescents)
13.5.5.2.2.2. Couples
13.5.5.2.2.3. Families
13.5.5.3. Australia
Cognitive Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By
Offerings
13.5.5.3.1. Online
13.5.5.3.2. Offline
13.5.6. South Korea
13.5.6.1. South
Korea Cognitive Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By
Services
13.5.6.1.1. Anxiety
Disorders
13.5.6.1.1.1. Generalized
Anxiety Disorders
13.5.6.1.1.2. Obsessive
Compulsive Disorder
13.5.6.1.1.3. Panic
Disorder
13.5.6.1.1.4. PTSD
13.5.6.1.1.5. Social
Anxiety Disorder
13.5.6.1.1.6. Specific
Phobia
13.5.6.1.2. Attention
Deficit Hyperactivity Disorder
13.5.6.1.3. Eating
Disorders
13.5.6.1.3.1. Anorexia
Nervosa
13.5.6.1.3.2. Binge
Eating Disorder
13.5.6.1.3.3. Bulimia
Nervosa
13.5.6.1.4. Mood
Disorders
13.5.6.1.4.1. Bipolar
Disorder
13.5.6.1.4.2. Depression
13.5.6.1.5. Psychotic
Disorders
13.5.6.1.6. Sexual
Disorders
13.5.6.1.7. Sleep
Disorders
13.5.6.1.8. Somatoform
Disorder
13.5.6.1.8.1. Body
Dysmorphic Disorder
13.5.6.1.8.2. Hypochondriasis
13.5.6.1.8.3. Pain
Disorder
13.5.6.1.8.4. Somatisation
Disorder
13.5.6.1.9. Substance
Use Disorders
13.5.6.2. South
Korea Cognitive Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By
End Users
13.5.6.2.1. B2B
13.5.6.2.2. B2C
13.5.6.2.2.1. Individuals (Adults, Children and Adolescents)
13.5.6.2.2.2. Couples
13.5.6.2.2.3. Families
13.5.6.3. South
Korea Cognitive Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By
Offerings
13.5.6.3.1. Online
13.5.6.3.2. Offline
13.5.7. Southeast
Asia
13.5.7.1. Southeast
Asia Cognitive Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By
Services
13.5.7.1.1. Anxiety
Disorders
13.5.7.1.1.1. Generalized
Anxiety Disorders
13.5.7.1.1.2. Obsessive
Compulsive Disorder
13.5.7.1.1.3. Panic
Disorder
13.5.7.1.1.4. PTSD
13.5.7.1.1.5. Social
Anxiety Disorder
13.5.7.1.1.6. Specific
Phobia
13.5.7.1.2. Attention
Deficit Hyperactivity Disorder
13.5.7.1.3. Eating
Disorders
13.5.7.1.3.1. Anorexia
Nervosa
13.5.7.1.3.2. Binge
Eating Disorder
13.5.7.1.3.3. Bulimia
Nervosa
13.5.7.1.4. Mood
Disorders
13.5.7.1.4.1. Bipolar
Disorder
13.5.7.1.4.2. Depression
13.5.7.1.5. Psychotic
Disorders
13.5.7.1.6. Sexual
Disorders
13.5.7.1.7. Sleep
Disorders
13.5.7.1.8. Somatoform
Disorder
13.5.7.1.8.1. Body
Dysmorphic Disorder
13.5.7.1.8.2. Hypochondriasis
13.5.7.1.8.3. Pain
Disorder
13.5.7.1.8.4. Somatisation
Disorder
13.5.7.1.9. Substance
Use Disorders
13.5.7.2. Southeast
Asia Cognitive Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By
End Users
13.5.7.2.1. B2B
13.5.7.2.2. B2C
13.5.7.2.2.1. Individuals (Adults, Children and Adolescents)
13.5.7.2.2.2. Couples
13.5.7.2.2.3. Families
13.5.7.3. Southeast
Asia Cognitive Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By
Offerings
13.5.7.3.1. Online
13.5.7.3.2. Offline
13.5.7.4. Southeast
Asia Cognitive Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By
Country
13.5.7.4.1. Indonesia
13.5.7.4.2. Thailand
13.5.7.4.3. Malaysia
13.5.7.4.4. Singapore
13.5.7.4.5. Rest
of Southeast Asia
13.5.8. Rest of
Asia Pacific
13.5.8.1. Rest
of Asia Pacific Cognitive Behavioural Therapy Market Revenue (US$ Mn) and
Forecasts, By Services
13.5.8.1.1. Anxiety
Disorders
13.5.8.1.1.1. Generalized
Anxiety Disorders
13.5.8.1.1.2. Obsessive
Compulsive Disorder
13.5.8.1.1.3. Panic
Disorder
13.5.8.1.1.4. PTSD
13.5.8.1.1.5. Social
Anxiety Disorder
13.5.8.1.1.6. Specific
Phobia
13.5.8.1.2. Attention
Deficit Hyperactivity Disorder
13.5.8.1.3. Eating
Disorders
13.5.8.1.3.1. Anorexia
Nervosa
13.5.8.1.3.2. Binge
Eating Disorder
13.5.8.1.3.3. Bulimia
Nervosa
13.5.8.1.4. Mood
Disorders
13.5.8.1.4.1. Bipolar
Disorder
13.5.8.1.4.2. Depression
13.5.8.1.5. Psychotic
Disorders
13.5.8.1.6. Sexual
Disorders
13.5.8.1.7. Sleep
Disorders
13.5.8.1.8. Somatoform
Disorder
13.5.8.1.8.1. Body
Dysmorphic Disorder
13.5.8.1.8.2. Hypochondriasis
13.5.8.1.8.3. Pain
Disorder
13.5.8.1.8.4. Somatisation
Disorder
13.5.8.1.9. Substance
Use Disorders
13.5.8.2. Rest
of Asia Pacific Cognitive Behavioural Therapy Market Revenue (US$ Mn) and
Forecasts, By End Users
13.5.8.2.1. B2B
13.5.8.2.2. B2C
13.5.8.2.2.1. Individuals (Adults, Children and Adolescents)
13.5.8.2.2.2. Couples
13.5.8.2.2.3. Families
13.5.8.3. Rest
of Asia Pacific Cognitive Behavioural Therapy Market Revenue (US$ Mn) and
Forecasts, By Offerings
13.5.8.3.1. Online
13.5.8.3.2. Offline
13.6. Key
Segment for Channeling Investments
13.6.1. By
Country
13.6.2. By
Services
13.6.3. By End
Users
13.6.4. By
Offerings
14. Middle
East and Africa Cognitive Behavioural Therapy Market Analysis and Forecasts,
2019 - 2027
14.1. Overview
14.1.1. Middle
East and Africa Cognitive Behavioural Therapy Market Revenue (US$ Mn)
14.2. Middle
East and Africa Cognitive Behavioural Therapy Market Revenue (US$ Mn) and
Forecasts, By Services
14.2.1. Anxiety
Disorders
14.2.1.1. Generalized
Anxiety Disorders
14.2.1.2. Obsessive
Compulsive Disorder
14.2.1.3. Panic
Disorder
14.2.1.4. PTSD
14.2.1.5. Social
Anxiety Disorder
14.2.1.6. Specific
Phobia
14.2.2. Attention
Deficit Hyperactivity Disorder
14.2.3. Eating
Disorders
14.2.3.1. Anorexia
Nervosa
14.2.3.2. Binge
Eating Disorder
14.2.3.3. Bulimia
Nervosa
14.2.4. Mood
Disorders
14.2.4.1. Bipolar
Disorder
14.2.4.2. Depression
14.2.5. Psychotic
Disorders
14.2.6. Sexual
Disorders
14.2.7. Sleep
Disorders
14.2.8. Somatoform
Disorder
14.2.8.1. Body
Dysmorphic Disorder
14.2.8.2. Hypochondriasis
14.2.8.3. Pain
Disorder
14.2.8.4. Somatisation
Disorder
14.2.9. Substance
Use Disorders
14.3. Middle
East and Africa Cognitive Behavioural Therapy Market Revenue (US$ Mn) and
Forecasts, By End Users
14.3.1. B2B
14.3.2. B2C
14.3.2.1. Individuals (Adults, Children and Adolescents)
14.3.2.2. Couples
14.3.2.3. Families
14.4. Middle
East and Africa Cognitive Behavioural Therapy Market Revenue (US$ Mn) and
Forecasts, By Offerings
14.4.1. Online
14.4.2. Offline
14.5. Middle
East and Africa Cognitive Behavioural Therapy Market Revenue (US$ Mn) and
Forecasts, By Country
14.5.1. Saudi
Arabia
14.5.1.1. Saudi
Arabia Cognitive Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By
Services
14.5.1.1.1. Anxiety
Disorders
14.5.1.1.1.1. Generalized
Anxiety Disorders
14.5.1.1.1.2. Obsessive
Compulsive Disorder
14.5.1.1.1.3. Panic
Disorder
14.5.1.1.1.4. PTSD
14.5.1.1.1.5. Social
Anxiety Disorder
14.5.1.1.1.6. Specific
Phobia
14.5.1.1.2. Attention
Deficit Hyperactivity Disorder
14.5.1.1.3. Eating
Disorders
14.5.1.1.3.1. Anorexia
Nervosa
14.5.1.1.3.2. Binge
Eating Disorder
14.5.1.1.3.3. Bulimia
Nervosa
14.5.1.1.4. Mood
Disorders
14.5.1.1.4.1. Bipolar
Disorder
14.5.1.1.4.2. Depression
14.5.1.1.5. Psychotic
Disorders
14.5.1.1.6. Sexual
Disorders
14.5.1.1.7. Sleep
Disorders
14.5.1.1.8. Somatoform
Disorder
14.5.1.1.8.1. Body
Dysmorphic Disorder
14.5.1.1.8.2. Hypochondriasis
14.5.1.1.8.3. Pain
Disorder
14.5.1.1.8.4. Somatisation
Disorder
14.5.1.1.9. Substance
Use Disorders
14.5.1.2. Saudi
Arabia Cognitive Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By
End Users
14.5.1.2.1. B2B
14.5.1.2.2. B2C
14.5.1.2.2.1. Individuals (Adults, Children and Adolescents)
14.5.1.2.2.2. Couples
14.5.1.2.2.3. Families
14.5.1.3. Saudi
Arabia Cognitive Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By
Offerings
14.5.1.3.1. Online
14.5.1.3.2. Offline
14.5.2. UAE
14.5.2.1. UAE Cognitive
Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By Services
14.5.2.1.1. Anxiety
Disorders
14.5.2.1.1.1. Generalized
Anxiety Disorders
14.5.2.1.1.2. Obsessive
Compulsive Disorder
14.5.2.1.1.3. Panic
Disorder
14.5.2.1.1.4. PTSD
14.5.2.1.1.5. Social
Anxiety Disorder
14.5.2.1.1.6. Specific
Phobia
14.5.2.1.2. Attention
Deficit Hyperactivity Disorder
14.5.2.1.3. Eating
Disorders
14.5.2.1.3.1. Anorexia
Nervosa
14.5.2.1.3.2. Binge
Eating Disorder
14.5.2.1.3.3. Bulimia
Nervosa
14.5.2.1.4. Mood
Disorders
14.5.2.1.4.1. Bipolar
Disorder
14.5.2.1.4.2. Depression
14.5.2.1.5. Psychotic
Disorders
14.5.2.1.6. Sexual
Disorders
14.5.2.1.7. Sleep
Disorders
14.5.2.1.8. Somatoform
Disorder
14.5.2.1.8.1. Body
Dysmorphic Disorder
14.5.2.1.8.2. Hypochondriasis
14.5.2.1.8.3. Pain
Disorder
14.5.2.1.8.4. Somatisation
Disorder
14.5.2.1.9. Substance
Use Disorders
14.5.2.2. UAE Cognitive
Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By End Users
14.5.2.2.1. B2B
14.5.2.2.2. B2C
14.5.2.2.2.1. Individuals (Adults, Children and Adolescents)
14.5.2.2.2.2. Couples
14.5.2.2.2.3. Families
14.5.2.3. UAE Cognitive
Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By Offerings
14.5.2.3.1. Online
14.5.2.3.2. Offline
14.5.3. Egypt
14.5.3.1. Egypt
Cognitive Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By
Services
14.5.3.1.1. Anxiety
Disorders
14.5.3.1.1.1. Generalized
Anxiety Disorders
14.5.3.1.1.2. Obsessive
Compulsive Disorder
14.5.3.1.1.3. Panic
Disorder
14.5.3.1.1.4. PTSD
14.5.3.1.1.5. Social
Anxiety Disorder
14.5.3.1.1.6. Specific
Phobia
14.5.3.1.2. Attention
Deficit Hyperactivity Disorder
14.5.3.1.3. Eating
Disorders
14.5.3.1.3.1. Anorexia
Nervosa
14.5.3.1.3.2. Binge
Eating Disorder
14.5.3.1.3.3. Bulimia
Nervosa
14.5.3.1.4. Mood
Disorders
14.5.3.1.4.1. Bipolar
Disorder
14.5.3.1.4.2. Depression
14.5.3.1.5. Psychotic
Disorders
14.5.3.1.6. Sexual
Disorders
14.5.3.1.7. Sleep
Disorders
14.5.3.1.8. Somatoform
Disorder
14.5.3.1.8.1. Body
Dysmorphic Disorder
14.5.3.1.8.2. Hypochondriasis
14.5.3.1.8.3. Pain
Disorder
14.5.3.1.8.4. Somatisation
Disorder
14.5.3.1.9. Substance
Use Disorders
14.5.3.2. Egypt
Cognitive Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By End
Users
14.5.3.2.1. B2B
14.5.3.2.2. B2C
14.5.3.2.2.1. Individuals (Adults, Children and Adolescents)
14.5.3.2.2.2. Couples
14.5.3.2.2.3. Families
14.5.3.3. Egypt
Cognitive Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By
Offerings
14.5.3.3.1. Online
14.5.3.3.2. Offline
14.5.4. Kuwait
14.5.4.1. Kuwait
Cognitive Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By
Services
14.5.4.1.1. Anxiety
Disorders
14.5.4.1.1.1. Generalized
Anxiety Disorders
14.5.4.1.1.2. Obsessive
Compulsive Disorder
14.5.4.1.1.3. Panic
Disorder
14.5.4.1.1.4. PTSD
14.5.4.1.1.5. Social
Anxiety Disorder
14.5.4.1.1.6. Specific
Phobia
14.5.4.1.2. Attention
Deficit Hyperactivity Disorder
14.5.4.1.3. Eating
Disorders
14.5.4.1.3.1. Anorexia
Nervosa
14.5.4.1.3.2. Binge
Eating Disorder
14.5.4.1.3.3. Bulimia
Nervosa
14.5.4.1.4. Mood
Disorders
14.5.4.1.4.1. Bipolar
Disorder
14.5.4.1.4.2. Depression
14.5.4.1.5. Psychotic
Disorders
14.5.4.1.6. Sexual
Disorders
14.5.4.1.7. Sleep
Disorders
14.5.4.1.8. Somatoform
Disorder
14.5.4.1.8.1. Body
Dysmorphic Disorder
14.5.4.1.8.2. Hypochondriasis
14.5.4.1.8.3. Pain
Disorder
14.5.4.1.8.4. Somatisation
Disorder
14.5.4.1.9. Substance
Use Disorders
14.5.4.2. Kuwait
Cognitive Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By End
Users
14.5.4.2.1. B2B
14.5.4.2.2. B2C
14.5.4.2.2.1. Individuals (Adults, Children and Adolescents)
14.5.4.2.2.2. Couples
14.5.4.2.2.3. Families
14.5.4.3. Kuwait
Cognitive Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By
Offerings
14.5.4.3.1. Online
14.5.4.3.2. Offline
14.5.5. South
Africa
14.5.5.1. South
Africa Cognitive Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By
Services
14.5.5.1.1. Anxiety
Disorders
14.5.5.1.1.1. Generalized
Anxiety Disorders
14.5.5.1.1.2. Obsessive
Compulsive Disorder
14.5.5.1.1.3. Panic
Disorder
14.5.5.1.1.4. PTSD
14.5.5.1.1.5. Social
Anxiety Disorder
14.5.5.1.1.6. Specific
Phobia
14.5.5.1.2. Attention
Deficit Hyperactivity Disorder
14.5.5.1.3. Eating
Disorders
14.5.5.1.3.1. Anorexia
Nervosa
14.5.5.1.3.2. Binge
Eating Disorder
14.5.5.1.3.3. Bulimia
Nervosa
14.5.5.1.4. Mood
Disorders
14.5.5.1.4.1. Bipolar
Disorder
14.5.5.1.4.2. Depression
14.5.5.1.5. Psychotic
Disorders
14.5.5.1.6. Sexual
Disorders
14.5.5.1.7. Sleep
Disorders
14.5.5.1.8. Somatoform
Disorder
14.5.5.1.8.1. Body
Dysmorphic Disorder
14.5.5.1.8.2. Hypochondriasis
14.5.5.1.8.3. Pain
Disorder
14.5.5.1.8.4. Somatisation
Disorder
14.5.5.1.9. Substance
Use Disorders
14.5.5.2. South
Africa Cognitive Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By
End Users
14.5.5.2.1. B2B
14.5.5.2.2. B2C
14.5.5.2.2.1. Individuals (Adults, Children and Adolescents)
14.5.5.2.2.2. Couples
14.5.5.2.2.3. Families
14.5.5.3. South
Africa Cognitive Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By
Offerings
14.5.5.3.1. Online
14.5.5.3.2. Offline
14.5.6. Rest of
Middle East & Africa
14.5.6.1. Rest
of Middle East & Africa Cognitive Behavioural Therapy Market Revenue (US$
Mn) and Forecasts, By Services
14.5.6.1.1. Anxiety
Disorders
14.5.6.1.1.1. Generalized
Anxiety Disorders
14.5.6.1.1.2. Obsessive
Compulsive Disorder
14.5.6.1.1.3. Panic
Disorder
14.5.6.1.1.4. PTSD
14.5.6.1.1.5. Social
Anxiety Disorder
14.5.6.1.1.6. Specific
Phobia
14.5.6.1.2. Attention
Deficit Hyperactivity Disorder
14.5.6.1.3. Eating
Disorders
14.5.6.1.3.1. Anorexia
Nervosa
14.5.6.1.3.2. Binge
Eating Disorder
14.5.6.1.3.3. Bulimia
Nervosa
14.5.6.1.4. Mood
Disorders
14.5.6.1.4.1. Bipolar
Disorder
14.5.6.1.4.2. Depression
14.5.6.1.5. Psychotic
Disorders
14.5.6.1.6. Sexual
Disorders
14.5.6.1.7. Sleep
Disorders
14.5.6.1.8. Somatoform
Disorder
14.5.6.1.8.1. Body
Dysmorphic Disorder
14.5.6.1.8.2. Hypochondriasis
14.5.6.1.8.3. Pain
Disorder
14.5.6.1.8.4. Somatisation
Disorder
14.5.6.1.9. Substance
Use Disorders
14.5.6.2. Rest
of Middle East & Africa Cognitive Behavioural Therapy Market Revenue (US$
Mn) and Forecasts, By End Users
14.5.6.2.1. B2B
14.5.6.2.2. B2C
14.5.6.2.2.1. Individuals (Adults, Children and Adolescents)
14.5.6.2.2.2. Couples
14.5.6.2.2.3. Families
14.5.6.3. Rest
of Middle East & Africa Cognitive Behavioural Therapy Market Revenue (US$
Mn) and Forecasts, By Offerings
14.5.6.3.1. Online
14.5.6.3.2. Offline
14.6. Key
Segment for Channeling Investments
14.6.1. By
Country
14.6.2. By
Services
14.6.3. By End
Users
14.6.4. By
Offerings
15. Latin
America Cognitive Behavioural Therapy Market Analysis and Forecasts, 2019 -
2027
15.1. Overview
15.1.1. Latin
America Cognitive Behavioural Therapy Market Revenue (US$ Mn)
15.2. Latin
America Cognitive Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By
Services
15.2.1. Anxiety
Disorders
15.2.1.1. Generalized
Anxiety Disorders
15.2.1.2. Obsessive
Compulsive Disorder
15.2.1.3. Panic
Disorder
15.2.1.4. PTSD
15.2.1.5. Social
Anxiety Disorder
15.2.1.6. Specific
Phobia
15.2.2. Attention
Deficit Hyperactivity Disorder
15.2.3. Eating
Disorders
15.2.3.1. Anorexia
Nervosa
15.2.3.2. Binge
Eating Disorder
15.2.3.3. Bulimia
Nervosa
15.2.4. Mood
Disorders
15.2.4.1. Bipolar
Disorder
15.2.4.2. Depression
15.2.5. Psychotic
Disorders
15.2.6. Sexual
Disorders
15.2.7. Sleep
Disorders
15.2.8. Somatoform
Disorder
15.2.8.1. Body
Dysmorphic Disorder
15.2.8.2. Hypochondriasis
15.2.8.3. Pain
Disorder
15.2.8.4. Somatisation
Disorder
15.2.9. Substance
Use Disorders
15.3. Latin
America Cognitive Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By
End Users
15.3.1. B2B
15.3.2. B2C
15.3.2.1. Individuals (Adults, Children and Adolescents)
15.3.2.2. Couples
15.3.2.3. Families
15.4. Latin
America Cognitive Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By
Offerings
15.4.1. Online
15.4.2. Offline
15.5. Latin
America Cognitive Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By
Country
15.5.1. Brazil
15.5.1.1. Brazil
Cognitive Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By
Services
15.5.1.1.1. Anxiety
Disorders
15.5.1.1.1.1. Generalized
Anxiety Disorders
15.5.1.1.1.2. Obsessive
Compulsive Disorder
15.5.1.1.1.3. Panic
Disorder
15.5.1.1.1.4. PTSD
15.5.1.1.1.5. Social
Anxiety Disorder
15.5.1.1.1.6. Specific
Phobia
15.5.1.1.2. Attention
Deficit Hyperactivity Disorder
15.5.1.1.3. Eating
Disorders
15.5.1.1.3.1. Anorexia
Nervosa
15.5.1.1.3.2. Binge
Eating Disorder
15.5.1.1.3.3. Bulimia
Nervosa
15.5.1.1.4. Mood
Disorders
15.5.1.1.4.1. Bipolar
Disorder
15.5.1.1.4.2. Depression
15.5.1.1.5. Psychotic
Disorders
15.5.1.1.6. Sexual
Disorders
15.5.1.1.7. Sleep
Disorders
15.5.1.1.8. Somatoform
Disorder
15.5.1.1.8.1. Body
Dysmorphic Disorder
15.5.1.1.8.2. Hypochondriasis
15.5.1.1.8.3. Pain
Disorder
15.5.1.1.8.4. Somatisation
Disorder
15.5.1.1.9. Substance
Use Disorders
15.5.1.2. Brazil
Cognitive Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By End
Users
15.5.1.2.1. B2B
15.5.1.2.2. B2C
15.5.1.2.2.1. Individuals (Adults, Children and Adolescents)
15.5.1.2.2.2. Couples
15.5.1.2.2.3. Families
15.5.1.3. Brazil
Cognitive Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By
Offerings
15.5.1.3.1. Online
15.5.1.3.2. Offline
15.5.2. Argentina
15.5.2.1. Argentina
Cognitive Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By
Services
15.5.2.1.1. Anxiety
Disorders
15.5.2.1.1.1. Generalized
Anxiety Disorders
15.5.2.1.1.2. Obsessive
Compulsive Disorder
15.5.2.1.1.3. Panic
Disorder
15.5.2.1.1.4. PTSD
15.5.2.1.1.5. Social
Anxiety Disorder
15.5.2.1.1.6. Specific
Phobia
15.5.2.1.2. Attention
Deficit Hyperactivity Disorder
15.5.2.1.3. Eating
Disorders
15.5.2.1.3.1. Anorexia
Nervosa
15.5.2.1.3.2. Binge
Eating Disorder
15.5.2.1.3.3. Bulimia
Nervosa
15.5.2.1.4. Mood
Disorders
15.5.2.1.4.1. Bipolar
Disorder
15.5.2.1.4.2. Depression
15.5.2.1.5. Psychotic
Disorders
15.5.2.1.6. Sexual
Disorders
15.5.2.1.7. Sleep
Disorders
15.5.2.1.8. Somatoform
Disorder
15.5.2.1.8.1. Body
Dysmorphic Disorder
15.5.2.1.8.2. Hypochondriasis
15.5.2.1.8.3. Pain
Disorder
15.5.2.1.8.4. Somatisation
Disorder
15.5.2.1.9. Substance
Use Disorders
15.5.2.2. Argentina
Cognitive Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By End
Users
15.5.2.2.1. B2B
15.5.2.2.2. B2C
15.5.2.2.2.1. Individuals (Adults, Children and Adolescents)
15.5.2.2.2.2. Couples
15.5.2.2.2.3. Families
15.5.2.3. Argentina
Cognitive Behavioural Therapy Market Revenue (US$ Mn) and Forecasts, By
Offerings
15.5.2.3.1. Online
15.5.2.3.2. Offline
15.5.3. Rest of
Latin America
15.5.3.1. Rest
of Latin America Cognitive Behavioural Therapy Market Revenue (US$ Mn) and
Forecasts, By Services
15.5.3.1.1. Anxiety
Disorders
15.5.3.1.1.1. Generalized
Anxiety Disorders
15.5.3.1.1.2. Obsessive
Compulsive Disorder
15.5.3.1.1.3. Panic
Disorder
15.5.3.1.1.4. PTSD
15.5.3.1.1.5. Social
Anxiety Disorder
15.5.3.1.1.6. Specific
Phobia
15.5.3.1.2. Attention
Deficit Hyperactivity Disorder
15.5.3.1.3. Eating
Disorders
15.5.3.1.3.1. Anorexia
Nervosa
15.5.3.1.3.2. Binge
Eating Disorder
15.5.3.1.3.3. Bulimia
Nervosa
15.5.3.1.4. Mood
Disorders
15.5.3.1.4.1. Bipolar
Disorder
15.5.3.1.4.2. Depression
15.5.3.1.5. Psychotic
Disorders
15.5.3.1.6. Sexual
Disorders
15.5.3.1.7. Sleep
Disorders
15.5.3.1.8. Somatoform
Disorder
15.5.3.1.8.1. Body
Dysmorphic Disorder
15.5.3.1.8.2. Hypochondriasis
15.5.3.1.8.3. Pain
Disorder
15.5.3.1.8.4. Somatisation
Disorder
15.5.3.1.9. Substance
Use Disorders
15.5.3.2. Rest
of Latin America Cognitive Behavioural Therapy Market Revenue (US$ Mn) and
Forecasts, By End Users
15.5.3.2.1. B2B
15.5.3.2.2. B2C
15.5.3.2.2.1. Individuals
(Adults, Children and Adolescents)
15.5.3.2.2.2. Couples
15.5.3.2.2.3. Families
15.5.3.3. Rest
of Latin America Cognitive Behavioural Therapy Market Revenue (US$ Mn) and
Forecasts, By Offerings
15.5.3.3.1. Online
15.5.3.3.2. Offline
15.6. Key
Segment for Channeling Investments
15.6.1. By
Country
15.6.2. By
Services
15.6.3. By End
Users
15.6.4. By
Offerings
16. Competitive
Benchmarking
16.1. Market
Share Analysis, 2018
16.2. Global
Presence and Growth Strategies
16.2.1. Mergers
and Acquisitions
16.2.2. Product
Launches
16.2.3. Investments
Trends
16.2.4. R&D
Initiatives
17. Player
Profiles
17.1. Angus
Munro Psychology
17.1.1. Company
Details
17.1.2. Company
Overview
17.1.3. Product
Offerings
17.1.4. Key
Developments
17.1.5. Financial
Analysis
17.1.6. SWOT
Analysis
17.1.7. Business
Strategies
17.2. Anxiety
Solutions CBT
17.2.1. Company
Details
17.2.2. Company
Overview
17.2.3. Product
Offerings
17.2.4. Key
Developments
17.2.5. Financial
Analysis
17.2.6. SWOT
Analysis
17.2.7. Business
Strategies
17.3. Associated
Counsellors & Psychologists
17.3.1. Company
Details
17.3.2. Company
Overview
17.3.3. Product
Offerings
17.3.4. Key
Developments
17.3.5. Financial
Analysis
17.3.6. SWOT
Analysis
17.3.7. Business
Strategies
17.4. CAMH
17.4.1. Company
Details
17.4.2. Company
Overview
17.4.3. Product
Offerings
17.4.4. Key
Developments
17.4.5. Financial
Analysis
17.4.6. SWOT
Analysis
17.4.7. Business
Strategies
17.5. CBT
Australia
17.5.1. Company
Details
17.5.2. Company
Overview
17.5.3. Product
Offerings
17.5.4. Key
Developments
17.5.5. Financial
Analysis
17.5.6. SWOT
Analysis
17.5.7. Business
Strategies
17.6. Cognitive
Behavioral Therapy Center
17.6.1. Company
Details
17.6.2. Company
Overview
17.6.3. Product
Offerings
17.6.4. Key
Developments
17.6.5. Financial
Analysis
17.6.6. SWOT
Analysis
17.6.7. Business
Strategies
17.7. Cognitive
Behavioral Therapy Los Angeles
17.7.1. Company
Details
17.7.2. Company
Overview
17.7.3. Product
Offerings
17.7.4. Key
Developments
17.7.5. Financial
Analysis
17.7.6. SWOT
Analysis
17.7.7. Business
Strategies
17.8. Cognitive
Behavioral Therapy Services
17.8.1. Company
Details
17.8.2. Company
Overview
17.8.3. Product
Offerings
17.8.4. Key
Developments
17.8.5. Financial
Analysis
17.8.6. SWOT
Analysis
17.8.7. Business
Strategies
17.9. DR
ELIZABETH WOODCOCK & ASSOCIATES
17.9.1. Company
Details
17.9.2. Company
Overview
17.9.3. Product
Offerings
17.9.4. Key
Developments
17.9.5. Financial
Analysis
17.9.6. SWOT
Analysis
17.9.7. Business
Strategies
17.10. First
Psychology Borders
17.10.1. Company
Details
17.10.2. Company
Overview
17.10.3. Product
Offerings
17.10.4. Key
Developments
17.10.5. Financial
Analysis
17.10.6. SWOT
Analysis
17.10.7. Business
Strategies
17.11. Fortis Healthcare
17.11.1. Company
Details
17.11.2. Company
Overview
17.11.3. Product
Offerings
17.11.4. Key
Developments
17.11.5. Financial
Analysis
17.11.6. SWOT
Analysis
17.11.7. Business
Strategies
17.12. Jewish
General Hospital (Integrated Health and Social Services University Network)
17.12.1. Company
Details
17.12.2. Company
Overview
17.12.3. Product
Offerings
17.12.4. Key
Developments
17.12.5. Financial
Analysis
17.12.6. SWOT
Analysis
17.12.7. Business
Strategies
17.13. LifeStance
Health Inc.
17.13.1. Company
Details
17.13.2. Company
Overview
17.13.3. Product
Offerings
17.13.4. Key
Developments
17.13.5. Financial
Analysis
17.13.6. SWOT
Analysis
17.13.7. Business
Strategies
17.14. Mayo
Foundation for Medical Education and Research
17.14.1. Company
Details
17.14.2. Company
Overview
17.14.3. Product
Offerings
17.14.4. Key
Developments
17.14.5. Financial
Analysis
17.14.6. SWOT
Analysis
17.14.7. Business
Strategies
17.15. Nuffield
Health
17.15.1. Company
Details
17.15.2. Company
Overview
17.15.3. Product
Offerings
17.15.4. Key
Developments
17.15.5. Financial
Analysis
17.15.6. SWOT
Analysis
17.15.7. Business
Strategies
17.16. Sydney
Clinical Psychology
17.16.1. Company
Details
17.16.2. Company
Overview
17.16.3. Product
Offerings
17.16.4. Key
Developments
17.16.5. Financial
Analysis
17.16.6. SWOT
Analysis
17.16.7. Business
Strategies
17.17. TELL
Japan
17.17.1. Company
Details
17.17.2. Company
Overview
17.17.3. Product
Offerings
17.17.4. Key
Developments
17.17.5. Financial
Analysis
17.17.6. SWOT
Analysis
17.17.7. Business
Strategies
17.18. themindworks
Clinics (HelloSelf Limited)
17.18.1. Company
Details
17.18.2. Company
Overview
17.18.3. Product
Offerings
17.18.4. Key
Developments
17.18.5. Financial
Analysis
17.18.6. SWOT
Analysis
17.18.7. Business
Strategies
17.19. Think
CBT
17.19.1. Company
Details
17.19.2. Company
Overview
17.19.3. Product
Offerings
17.19.4. Key
Developments
17.19.5. Financial
Analysis
17.19.6. SWOT
Analysis
17.19.7. Business
Strategies
17.20. Tokyo
Mental Health
17.20.1. Company
Details
17.20.2. Company
Overview
17.20.3. Product
Offerings
17.20.4. Key
Developments
17.20.5. Financial
Analysis
17.20.6. SWOT
Analysis
17.20.7. Business
Strategies
17.21. Other
Industry Participants
18. Key
Findings
Note: This ToC is tentative
and can be changed according to the research study conducted during the course
of report completion.
**Exclusive for Multi-User and
Enterprise User.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
Reach to us
Call us on
+91-74002-42424
Drop us an email at
sales@absolutemarketsinsights.com
Why Absolute Markets Insights?
An effective strategy is the entity that influences a business to stand out of the crowd. An organization with a phenomenal strategy for success dependably has the edge over the rivals in the market. It offers the organizations a head start in planning their strategy. Absolute Market Insights is the new initiation in the industry that will furnish you with the lead your business needs. Absolute Market Insights is the best destination for your business intelligence and analytical solutions; essentially because our qualitative and quantitative sources of information are competent to give one-stop solutions. We inventively combine qualitative and quantitative research in accurate proportions to have the best report, which not only gives the most recent insights but also assists you to grow.